|
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
1 |
[GO] |
2022―Apr―06 |
Pandemic-related supply chain disruptions in cell therapy require rapid qualification for single-sourced materials |
John Duguid, Paul Friedman |
2 |
[GO] |
2022―Jan―28 |
Pandemic-related trends and challenges in adult donor stem cell and cord blood collection, banking, and processing |
Heidi Elmoazzen |
3 |
[GO] |
2022―Jan―17 |
COVID-19 vaccine approvals: key lessons for mRNA therapeutics |
Venkata Indurthi, PhD, Joseph Barberio, Scott Zobbi, Dr. Christoph Kröner |
4 |
[GO] |
2021―Okt―12 |
Leveraging lessons from the COVID-19 pandemic to accelerate the development and production of viral-based gene therapies |
Yasser Kehail |
5 |
[GO] |
2021―Aug―20 |
COVID-19 mRNA vaccine approvals: key lessons for cell & gene therapy and mRNA therapeutic development |
Joseph Barberio, Christoph Kröner, Venkata Indurthi, Scott Zobbi |
6 |
[GO] |
2021―Apr―12 |
Expect the unexpected: maintaining and optimizing a cell collection network during COVID-19 |
Amy Hines |
7 |
[GO] |
2021―Mrz―24 |
Considerations for performing virtual quality audits on manufacturers of gene therapy viral vectors: an auditor’s perspective during the COVID-19 public health emergency |
Gary C du Moulin, PhD, MPH, RAC |
8 |
[GO] |
2021―Mrz―23 |
The importance of a strong collection cell collection network during the COVID-19 pandemic |
Chris McClain, MBA |
9 |
[GO] |
2021―Jan―20 |
Navigating cell therapy supply chain complexities during the COVID-19 pandemic |
Erin Rasch |
10 |
[GO] |
2020―Nov―10 |
Managing donor collections during the COVID-19 pandemic |
Joy Aho |
11 |
[GO] |
2020―Aug―12 |
Targeting lung damage in COVID-19 patients with CD34+ cell therapy |
Douglas Losordo |
12 |
[GO] |
2020―Aug―12 |
Clinical trials in the era of Covid-19: successes, failures & ongoing challenges |
Sven Kili |
13 |
[GO] |
2020―Aug―12 |
Fighting a global pandemic with an army of robots |
Rennos Fragkoudis, Nikolaos Pantidos |
14 |
[GO] |
2020―Jul―16 |
Regulatory affairs in regen med: building trust, expediting development and navigating the impact of COVID-19 |
Manal Morsy |
15 |
[GO] |
2020―Jun―10 |
How will COVID-19 impact the cord blood banking sector? |
WOUTER VAN’T HOF |
16 |
[GO] |
2020―Mai―21 |
Cell therapy’s role in defeating Covid-19 |
Yaky Yanay |